Extract from the Register of European Patents

EP About this file: EP2155200

EP2155200 - CRYSTALLINE FORM OF A CARBAMOYL-CYCLOHEXANE DERIVATIVE [Right-click to bookmark this link]
Former [2010/08]NOVEL SOLVATE AND CRYSTALLINE FORMS OF CARBAMOYL-CYCLOHEXANE DERIVATIVES
[2016/28]
StatusNo opposition filed within time limit
Status updated on  13.10.2017
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  04.11.2016
FormerGrant of patent is intended
Status updated on  31.10.2016
Most recent event   Tooltip13.10.2017No opposition filed within time limitpublished on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Richter Gedeon Nyrt.
Gyömröi út 19-21
1103 Budapest / HU
[2010/08]
Inventor(s)01 / LIAO, Xiangmin
35 Harvard Lane
Commack, NY 11725 / US
02 / ZHU, Haijian
8 Milleridge Lane
Smithtown, NY 11787 / US
03 / GRILL, Andreas
5 June Street
Hauppauge, NY 11788 / US
 [2010/08]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2016/49]
Former [2010/08]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date08755214.709.05.2008
[2010/08]
WO2008US63181
Priority number, dateUS20070917383P11.05.2007         Original published format: US 917383 P
[2010/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008141135
Date:20.11.2008
Language:EN
[2008/47]
Type: A1 Application with search report 
No.:EP2155200
Date:24.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2008 takes the place of the publication of the European patent application.
[2010/08]
Type: B1 Patent specification 
No.:EP2155200
Date:07.12.2016
Language:EN
[2016/49]
Search report(s)International search report - published on:US20.11.2008
(Supplementary) European search report - dispatched on:EP07.12.2011
ClassificationIPC:A61K31/497, A61K31/4965
[2010/08]
CPC:
C07D295/135 (EP,US); C07D241/04 (KR); A61K31/4965 (KR);
A61K31/497 (KR); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/49]
Former [2010/08]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:KRISTALLINE FORM EINES CARBAMOYL-CYCLOHEXAN-DERIVATS[2016/28]
English:CRYSTALLINE FORM OF A CARBAMOYL-CYCLOHEXANE DERIVATIVE[2016/28]
French:FORME CRISTALLINE D'UN DÉRIVÉ DE CARBAMOYLE-CYCLOHEXANE[2016/28]
Former [2010/08]NEUE SOLVAT- UND KRISTALLINE FORMEN VON CARBAMOYL-CYCLOHEXAN-DERIVATEN
Former [2010/08]NOVEL SOLVATE AND CRYSTALLINE FORMS OF CARBAMOYL-CYCLOHEXANE DERIVATIVES
Former [2010/08]NOUVEAU SOLVATE ET FORMES CRISTALLINES DE DÉRIVÉS DE CARBAMOYLE-CYCLOHEXANE
Entry into regional phase09.12.2009National basic fee paid 
09.12.2009Search fee paid 
09.12.2009Designation fee(s) paid 
09.12.2009Examination fee paid 
Examination procedure09.12.2009Examination requested  [2010/08]
05.07.2012Amendment by applicant (claims and/or description)
05.08.2014Despatch of a communication from the examining division (Time limit: M04)
11.12.2014Reply to a communication from the examining division
18.03.2015Despatch of a communication from the examining division (Time limit: M06)
25.09.2015Reply to a communication from the examining division
07.06.2016Date of oral proceedings
05.07.2016Minutes of oral proceedings despatched
07.07.2016Communication of intention to grant the patent
26.10.2016Fee for grant paid
26.10.2016Fee for publishing/printing paid
26.10.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.08.2014
Opposition(s)08.09.2017No opposition filed within time limit [2017/46]
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
24.05.2011Renewal fee patent year 04
23.03.2012Renewal fee patent year 05
27.05.2013Renewal fee patent year 06
13.03.2014Renewal fee patent year 07
21.05.2015Renewal fee patent year 08
20.05.2016Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[ID] WO2005012266  (RICHTER GEDEON VEGYESZET et al.) [ID] 1-22 * claims 1,5,11,15; compound 1 * * page 4, line 8 - line 12 * * page 11, line 26 - page 12, line 19 * * page 19, line 25 - page 20, line 3 *
International search[Y]   GUREVICH ET AL.: "Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study", ARCHIVES OF GENERAL PSYCHIATRY, vol. 54, 1997, pages 225 - 232, XP008134819 [Y]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.